Inferra AI / Company / UHS
Universal Health Services
UHS · Health Care
Last earnings Oct 27, 2026
Key results
Net incomequarter
$373.0 million
(NYSE: UHS) announced today that its reported net income attributable to UHS was $373.0 million, or $5.86 per diluted share, during the third quarter of 2025, as compared to $258.7 million, or $3.80 per diluted share, during the third quarter of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Net revenuequarter
13.4%
Net revenues increased by 13.4% to $4.495 billion during the third quarter of 2025, as compared to $3.963 billion during the third quarter of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Adjusted net incomequarter
$362.3 million
As reflected on the Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), our adjusted net income attributable to UHS during the third quarter of 2025 was $362.3 million, or $5.69 per diluted share, as compared to $252.5 million, or $3.71 per diluted share, during the third quarter of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Reported net incomequarter
$1.043 billion
Consolidated Results of Operations, As Reported and As Adjusted – Nine-month periods ended September 30, 2025 and 2024: Reported net income attributable to UHS was $1.043 billion, or $16.07 per diluted share, during the first nine months of 2025, as compared to $809.7 million, or $11.88 per diluted share, during the comparable period of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Net revenueQ3 2025
9.9%
Net revenues increased by 9.9% to $12.879 billion during the first nine months of 2025, as compared to $11.714 billion during the comparable period of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Net revenueytd
$12.879 billion
Net revenues increased by 9.9% to $12.879 billion during the first nine months of 2025, as compared to $11.714 billion during the comparable period of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Adjusted net incomeytd
$1.030 billion
As reflected on the Supplemental Schedule, our adjusted net income attributable to UHS during the first nine months of 2025 was $1.030 billion, or $15.87 per diluted share, as compared to $798.2 million, or $11.71 per diluted share, during the comparable period of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Revenuequarter
9.8%
At these facilities, during the third quarter of 2025, net revenue per adjusted admission increased by 9.8% while net revenue per adjusted patient day increased by 11.5%, as compared to the third quarter of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Revenueytd
5.4%
At these facilities, during the first nine months of 2025, net revenue per adjusted admission increased by 5.4% while net revenue per adjusted patient day increased by 7.0%, as compared to the comparable period of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
RevenueQ3 2025
7.0%
At these facilities, during the first nine months of 2025, net revenue per adjusted admission increased by 5.4% while net revenue per adjusted patient day increased by 7.0%, as compared to the comparable period of 2024.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
AI analysis
Q3 2025 · reported Oct 28, 2025
Based on: Earnings release + parent 8-K — transcript not held
Headline figures
| Metric | Q3 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Net income | $373.0 million | — | — |
| Net revenue | 13.4% | — | — |
| Adjusted net income | $362.3 million | — | — |
| Reported net income | $1.043 billion | — | — |
| Revenue | 9.8% | — | — |
Guidance · company-stated
Direction: Raised
“ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2025 and 2024: KING OF PRUSSIA, PA – Universal Health Services, Inc.”
“Revised Forecast Previous Forecast For the Year Ended For the Year Ended December 31, 2025 December 31, 2025 Low High Low High Net revenues $17.306 billion $17.445 billion $17.096 billion $17.312 billion Adjusted EBITDA, net of NCI $2.569 billion $2.619 billion $2.458 billion $2.543 billion Adjusted EPS – diluted $21.50 per share $22.10 per share $20.00 per share $21.00 per share • The midpoint of our revised 2025 forecasted net revenues represents an increase of 1.0% over the midpoint our previous range of 2025 forecasted net revenues.”
“• The midpoint of our revised 2025 forecasted Adjusted EBITDA, net of NCI, represents an increase of 3.9% over the midpoint of our previous range of 2025 forecasted Adjusted EBITDA, net of NCI.”
“• The midpoint of our revised 2025 forecasted Adjusted EPS-diluted represents an increase of 6.4% over the midpoint of our previous range of 2025 forecasted Adjusted EPS-diluted.”
Classified from the release's primary full-year outlook statement.
Capital allocation
ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2025 and 2024: KING OF PRUSSIA, PA – Universal Health Services, Inc.
Liquidity: As of September 30, 2025, we had $965 million of aggregate available borrowing capacity pursuant to our $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit.
Event summary
Universal Health Services Q3 2025 — (NYSE: UHS) announced today that its reported net income attributable to UHS was $373.0 million, or $5.86 per diluted share, during the third quarter of 2025, as compared to $258.7 million, or $3.80 p…
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
Direction: Raised
Company outlook: “ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2025 and 2024: KING OF PRUSSIA, PA – Universal Health Services, Inc.”
Revenue: “Revised Forecast Previous Forecast For the Year Ended For the Year Ended December 31, 2025 December 31, 2025 Low High Low High Net revenues $17.306 billion $17.445 billion $17.096 billion $17.312 billion Adjusted EBITDA, net of NCI $2.569 billion $2.619 billion $2.458 billion $2.543 billion Adjusted EPS – diluted $21.50 per share $22.10 per share $20.00 per share $21.00 per share • The midpoint of our revised 2025 forecasted net revenues represents an increase of 1.0% over the midpoint our previous range of 2025 forecasted net revenues.”
Company outlook: “• The midpoint of our revised 2025 forecasted Adjusted EBITDA, net of NCI, represents an increase of 3.9% over the midpoint of our previous range of 2025 forecasted Adjusted EBITDA, net of NCI.”
EPS: “• The midpoint of our revised 2025 forecasted Adjusted EPS-diluted represents an increase of 6.4% over the midpoint of our previous range of 2025 forecasted Adjusted EPS-diluted.”
Company outlook — Raised (“INCREASES”)
“ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2025 and 2024: KING OF PRUSSIA, PA – Universal Health Services, Inc.”
Revenue — Raised (“increasing”)
“, as indicated on the Revised Forecast table below, we are increasing our operating results forecast range for consolidated net revenues, adjusted earnings before interest, taxes, depreciation & amortization, and the impacts of other income/expense and net income attributable to noncontrolling interests (“Adjusted EBITDA, net of NCI”), and adjusted net income attributable to UHS per diluted share (“Adjusted EPS-diluted”) for the year ended December 31, 2025.”
Revenue — Raised (“increase”)
“Revised Forecast Previous Forecast For the Year Ended For the Year Ended December 31, 2025 December 31, 2025 Low High Low High Net revenues $17.306 billion $17.445 billion $17.096 billion $17.312 billion Adjusted EBITDA, net of NCI $2.569 billion $2.619 billion $2.458 billion $2.543 billion Adjusted EPS – diluted $21.50 per share $22.10 per share $20.00 per share $21.00 per share • The midpoint of our revised 2025 forecasted net revenues represents an increase of 1.0% over the midpoint our previous range of 2025 forecasted net revenues.”
Company outlook — Raised (“increase”)
“• The midpoint of our revised 2025 forecasted Adjusted EBITDA, net of NCI, represents an increase of 3.9% over the midpoint of our previous range of 2025 forecasted Adjusted EBITDA, net of NCI.”
EPS — Raised (“increase”)
“• The midpoint of our revised 2025 forecasted Adjusted EPS-diluted represents an increase of 6.4% over the midpoint of our previous range of 2025 forecasted Adjusted EPS-diluted.”
Classified from the release's primary full-year outlook statement.
Capital allocation
ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 30, 2025 and 2024: KING OF PRUSSIA, PA – Universal Health Services, Inc.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Liquidity: As of September 30, 2025, we had $965 million of aggregate available borrowing capacity pursuant to our $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Increased Authorization to Stock Repurchase Program: On October 27, 2025, our Board of Directors authorized a $1.5 billion increase to our stock repurchase program.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Pursuant to this program, which including today’s increased authorization has a current aggregate available repurchase authorization of $1.759 billion, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Pursuant to this program, during the third quarter of 2025, we have repurchased 1.315 million shares at an aggregate cost of approximately $234.3 million (average price of approximately $178 per share).
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
During the first nine months of 2025, we have repurchased 3.190 million shares at an aggregate cost of approximately $565.8 million (average price of approximately $177 per share).
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Strategy & priorities
Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Risks & headwinds
These statements are subject to risks and uncertainties and therefore actual results may differ materially.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
• Changes in laws or policies governing the terms of foreign trade, and in particular, increased trade restrictions, tariffs or taxes on imports from where our products or materials are made (either directly or through our suppliers) could have an impact on our competitive position, business operations and financial results.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
• The outcome of known and unknown litigation, liabilities and other claims asserted against us and/or our subsidiaries, including, but not limited to, the matters related to Cumberland Hospital for Children and Adolescents, located in New Kent, Virginia, as previously disclosed in various filings including, most recently, our Form 10-Q for the quarterly period ended June 30, 2025, and the verdict in Washoe County, Nevada, against certain subsidiaries of ours, as previously disclosed on Form 8-K as filed on September 29, 2025.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods.
SEC original ↗Universal Health Services — Earnings release (8-K exhibit)EX-99Oct 28, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
31 documents- Q3 2026
- 8-KUHS
Oct 27, 2026
- Q2 2026
- 8-KUHS
Aug 21, 2026
- 8-KUHS
Aug 17, 2026
- 8-KUHS
Aug 13, 2026
- 10-QUHS
- 8-KUHS
Jul 28, 2026
- 8-KUHS
Jul 21, 2026
- Q1 2026
- 8-KUHS
May 22, 2026
- 8-KUHS
May 21, 2026
- 10-QUHS
- 8-KUHS
Apr 28, 2026
- 8-KUHS
Apr 24, 2026
- Q4 2025
- 8-KUHS
Mar 30, 2026
- 8-KUHS
- 8-KUHS
Feb 26, 2026
- 10-KUHS
Feb 25, 2026
- Q3 2025
- 8-KUHS
Dec 31, 2025
- 10-QUHS
- 8-KUHS
Oct 28, 2025
- Q2 2025
- 8-KUHS
Sep 29, 2025
- 10-QUHS
- 8-KUHS
Jul 29, 2025
- Q1 2025
- 8-KUHS
May 15, 2025
- 10-QUHS
- 8-KUHS
Apr 29, 2025
- Q4 2024
- 8-KUHS
Mar 20, 2025
- 8-KUHS
Feb 27, 2025
- 10-KUHS
Feb 26, 2025
- Q3 2024
- 10-QUHS
- 8-KUHS
Oct 25, 2024
- 8-KUHS
Oct 11, 2024
Earnings releases
10 documentsPresentations
0 documentsNo presentations for Universal Health Services are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Universal Health Services are held in this edition of the library.
Mentioned by
2 companiesOther tracked companies whose held documents mention Universal Health Services by name or ticker. A mention is counted once per document, from the document text the library holds.
“…uhs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc. Creates nation's first full continuum of behavioral healthcare services, supporting… …d”
“ 669,898 Basic earnings per share attributable to UHS (a) $ 6.01 $ 5.49 $ 11.71 $ 10.36… …disclosed, during the full year of 2026, we expect to spend approximately $950 million to ”
See also the earnings calendar for every tracked company’s next earnings date.